Nicotinamide as a treatment option of Age-Related Macular Degeneration
Article Sidebar
Main Article Content
Article Details
Copyright (c) 2017 Lin Y, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Stem Cell Therapy and Transplantation is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Stem Cell Therapy and Transplantation is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Whitmore SS, Sohn EH, Chirco KR, Drack AV, Stone EM, et al. Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res. 2015; 45: 1-29. Ref.: https://goo.gl/84HxeU
Hollyfield JG, Salomon RG, Crabb JW. Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol. 2003; 533: 83-89. Ref.: https://goo.gl/cTzE5Q
Al-Zamil WM, Yassin SA. Recent developments in age-related macular degeneration: a review. Clin Interv Aging. 2017; 12: 1313-1330. Ref.: https://goo.gl/UeZCz6
Saini JS, Corneo B, Miller JD, Kiehl TR, Wang Q, et al. Nicotinamide Ameliorates Disease Phenotypes in a Human iPSC Model of Age-Related Macular Degeneration. Cell Stem Cell. 2017; 20: 635-647. Ref.: https://goo.gl/rUuJCm
Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, et al. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci. 2008; 28: 11500-11510. Ref.: https://goo.gl/kH7jna
Maiese K, Chong ZZ, Hou J, Shang YC. The vitamin nicotinamide: translating nutrition into clinical care. Molecules. 2009; 14: 3446-3485. Ref.: https://goo.gl/uAYMfT
Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016; 48: 134-143. Ref.: https://goo.gl/9mywt3
Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, et al. Abundant lipid and protein components of drusen. PLoS One. 2010; 5: 10329. Ref.: https://goo.gl/oa36ye
Hollyfield JG, Salomon RG, Crabb JW. Proteomic approaches to understanding age-related macular degeneration. Adv Exp Med Biol. 2003; 533: 83-89. Ref.: https://goo.gl/ohJxsj
Micklisch S, Lin Y, Jacob S, Karlstetter M, Dannhausen K, et al. Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator. J Neuroinflammation. 2017; 14: 4. Ref.: https://goo.gl/yzbfzx
Calippe B, Augustin S, Beguier F, Charles-Messance H, Poupel L, et al. Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation. Immunity. 2017; 46: 261-272. Ref.: https://goo.gl/ke5hWL
Liszewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity. 2013; 39: 1143-1157. Ref.: https://goo.gl/WrEScT
Hawksworth OA, Coulthard LG, Woodruff TM. Complement in the fundamental processes of the cell. Mol Immunol. 2017; 84: 17-25. Ref.: https://goo.gl/68gxE3
Maiese K, Chong ZZ, Hou J, Shang YC. The vitamin nicotinamide: translating nutrition into clinical care. Molecules. 2009; 14: 3446-3485. Ref.: https://goo.gl/6UVF48